Hippo Holdings (HIPO) Cash & Equivalents (2020 - 2026)

Hippo Holdings has reported Cash & Equivalents for 7 years, with the latest figure at $275.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 52.83% year-over-year to $275.4 million; the trailing twelve-month figure through Mar 2026 stood at $275.4 million (up 52.83% YoY), and the FY2025 full-year result was $218.3 million, down 6.23% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $275.4 million, up from $218.3 million in the prior quarter.
• The five-year high for Cash & Equivalents was $392.9 million in Q3 2022, with the low at $180.2 million in Q1 2025.
• Historically, Cash & Equivalents has averaged $255.0 million across 5 years, with a median of $238.4 million in 2023.
• The largest YoY upside for Cash & Equivalents was 321044.04% in 2022 against a maximum downside of 70.14% in 2022.
• Hippo Holdings' Cash & Equivalents stood at $244.5 million in 2022, then declined by 20.2% to $195.1 million in 2023, then gained by 19.32% to $232.8 million in 2024, then slipped by 6.23% to $218.3 million in 2025, then grew by 26.16% to $275.4 million in 2026.
• The last three Cash & Equivalents figures came in at $275.4 million (Q1 2026), $218.3 million (Q4 2025), and $247.7 million (Q3 2025), per Business Quant data.